Proglycem (Teva Branded Pharmaceutical Products R&D, Inc.)


Welcome to the PulseAid listing for the Proglycem drug offered from Teva Branded Pharmaceutical Products R&D, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Teva Branded Pharmaceutical Products R&D, Inc.
NON-PROPRIETARY NAME: diazoxide
SUBSTANCE NAME: DIAZOXIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: SUSPENSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1990-09-30
END MARKETING DATE: 0000-00-00


Proglycem HUMAN PRESCRIPTION DRUG Details:

Item DescriptionProglycem from Teva Branded Pharmaceutical Products R&D, Inc.
LABELER NAME: Teva Branded Pharmaceutical Products R&D, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/mL)
START MARKETING DATE: 1990-09-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0575-6200_a2410f90-c096-4421-8f1b-04c136018cea
PRODUCT NDC: 0575-6200
APPLICATION NUMBER: NDA017453

Other DIAZOXIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Teva Branded Pharmaceutical Products R&D, Inc.Proglycem